Back
SpringWorks Therapeutics Stock Price Chart
Buy
64
SWTX
SpringWorks Therapeutics
Last Price:
44.86
Seasonality Move:
0.17%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.16 | Buy |
| 20-day SMA: | 44.29 | Buy |
| 50-day SMA: | 45.88 | Sell |
| 200-day SMA: | 35.54 | Buy |
| 8-day EMA: | 44.03 | Buy |
| 20-day EMA: | 44.19 | Buy |
| 50-day EMA: | 44.76 | Buy |
| 200-day EMA: | 38.67 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 51.29 | Buy |
| Chaikin Money Flow: | 560629 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.14 - 45.72) | Buy |
| Bollinger Bands (100): | (41.05 - 49.21) | Sell |
SpringWorks Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 44.84 while SWTX 8-day simple moving average is 43.16, which is a Buy signal.
- The stock price of SWTX is 44.84 while SpringWorks Therapeutics 20-day SMA is 44.29, which makes it a Buy.
- SpringWorks Therapeutics 50-day simple moving average is 45.88 while SWTX share price is 44.84, making it a Sell technically.
- SWTX stock price is 44.84 and SpringWorks Therapeutics 200-day simple moving average is 35.54, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Buy
The current SpringWorks Therapeutics [SWTX] share price is $44.84. The Score for SWTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.32B
Price in USD:
44.84
Share Volume:
693.25K
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
18.00
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?
The SpringWorks Therapeutics stock price is 44.84 USD today. -
Will SWTX stock go up or go down?
SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is SpringWorks Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is not overvalued.
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 44.84 while SWTX 8-day exponential moving average is 44.03, which is a Buy signal.
- The stock price of SWTX is 44.84 while SpringWorks Therapeutics 20-day EMA is 44.19, which makes it a Buy.
- SpringWorks Therapeutics 50-day exponential moving average is 44.76 while SWTX share price is 44.84, making it a Buy technically.
- SWTX stock price is 44.84 and SpringWorks Therapeutics 200-day simple moving average is 38.67, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $1.72 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
- SWTX Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting SpringWorks Therapeutics is a Sell
- SpringWorks Therapeutics Relative Strength Index (RSI) is 51.29, which suggest SpringWorks Therapeutics is overbought
- The Bollinger Bands (25) for SpringWorks Therapeutics is (42.14 - 45.72), which suggest SpringWorks Therapeutics is a Sell
- The Bollinger Bands (100) for SpringWorks Therapeutics is (41.05 - 49.21), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.